Signet Financial Management, LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Signet Financial Management, LLC

  • $765 Million
  • Q4 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $1.01 Million - $1.21 Million
-3,000 Reduced 85.71%
500 $1,000
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $1.05 Million - $1.23 Million
3,000 Added 600.0%
3,500 $110,000
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $142,300 - $172,495
500 New
500 $19,000

Others Institutions Holding REGN

# of Institutions
1,500
Shares Held
83M
Call Options Held
1.22M
Put Options Held
1.5M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Signet Financial Management, LLC Portfolio

Follow Signet Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email